Recurrence pattern with respect to two different dose fractionations in patients with locally advanced head and neck cancer treated with chemoradiation using image-guided volumetric arc therapy

Head Neck. 2022 Jul;44(7):1690-1701. doi: 10.1002/hed.27075. Epub 2022 May 10.

Abstract

Background: Patients with head and neck cancer were treated with either 70 Gy in 35 fractions (Arm A) or 66 Gy in 30 fractions (Arm B).

Materials and methods: Total 168 patients of carcinoma oropharynx, larynx, and hypopharynx treated with radical chemoradiation in two Arm A versus B (65 vs. 103 patients).

Results: With a median follow-up of 16 months (0-67), 2 year disease-free survival (DFS) and overall survival (OS) was 56.3% versus 62.1% (p = 0.64) and 44.5% versus 53.0% (p = 0.51) in Arm A versus B. Total 22 (33.8%) versus 28 (27.2%) failed locoregionally. Majority of failures were infield for both primary (17 vs. 23 cases) and nodes (13 vs. 12) in Arm A versus B. Ten (71.4%) vs. 10 (76.9%) had nodal failure in index nodal level only.

Conclusion: Commonly seen failure in head-neck radical chemoradiation is within infield high-risk volume, nodal failure being most common in index nodal level.

Keywords: IGRT; IMRT; VMAT; cancer; chemoradiation; fractionation; head and neck; recurrence.

MeSH terms

  • Chemoradiotherapy / methods
  • Dose Fractionation, Radiation
  • Head and Neck Neoplasms* / therapy
  • Humans
  • Neck
  • Oropharyngeal Neoplasms*
  • Radiotherapy, Intensity-Modulated* / methods